• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impact of high-dose statin pre-treatment and contrast-induced acute kidney injury on follow-up events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

作者信息

Patti Giuseppe, Leoncini Mario, Toso Anna, Maioli Mauro, Grieco Domenico, Colonna Giuseppe, Bellandi Francesco, Di Sciascio Germano

机构信息

Department of Cardiovascular Sciences, Campus-Bio Medico University of Rome, Italy.

Cardiology Division, Prato Hospital, Italy.

出版信息

Int J Cardiol. 2014 Jun 15;174(2):440-1. doi: 10.1016/j.ijcard.2014.04.026. Epub 2014 Apr 13.

DOI:10.1016/j.ijcard.2014.04.026
PMID:24767765
Abstract
摘要

相似文献

1
Impact of high-dose statin pre-treatment and contrast-induced acute kidney injury on follow-up events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.大剂量他汀类药物预处理及对比剂诱导的急性肾损伤对接受经皮冠状动脉介入治疗的急性冠脉综合征患者随访事件的影响。
Int J Cardiol. 2014 Jun 15;174(2):440-1. doi: 10.1016/j.ijcard.2014.04.026. Epub 2014 Apr 13.
2
Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study.早期大剂量瑞舒伐他汀与心脏保护作用——瑞舒伐他汀与抗血小板治疗对急性冠脉综合征患者对比剂诱导的急性肾损伤和心肌损伤的保护作用（PRATO-ACS 研究）
Am Heart J. 2014 Nov;168(5):792-7. doi: 10.1016/j.ahj.2014.08.005. Epub 2014 Aug 10.
3
Meta-analysis of short-term high versus low doses of atorvastatin preventing contrast-induced acute kidney injury in patients undergoing coronary angiography/percutaneous coronary intervention.阿托伐他汀短期高剂量与低剂量预防冠状动脉造影/经皮冠状动脉介入治疗患者对比剂诱导急性肾损伤的荟萃分析。
J Clin Pharmacol. 2015 Feb;55(2):123-31. doi: 10.1002/jcph.411. Epub 2015 Jan 5.
4
Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention).炎症与早期大剂量瑞舒伐他汀对急性冠脉综合征患者对比剂肾病获益的关系：PRATO-ACS 研究中的病理生理学联系（瑞舒伐他汀和抗血小板治疗对接受经皮冠状动脉介入治疗的急性冠脉综合征患者对比剂肾病和心肌损伤的保护作用）。
JACC Cardiovasc Interv. 2014 Dec;7(12):1421-9. doi: 10.1016/j.jcin.2014.06.023.
5
[The Saturn study].[土星研究]
G Ital Cardiol (Rome). 2012 Jul-Aug;13(7-8):469-73. doi: 10.1714/1114.12242.
6
Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome).急性冠状动脉综合征中早期大剂量瑞舒伐他汀预防造影剂肾病：来自 PRATO-ACS 研究的结果（瑞舒伐他汀和抗血小板治疗对急性冠状动脉综合征患者造影剂诱导的急性肾损伤和心肌损伤的保护作用）。
J Am Coll Cardiol. 2014;63(1):71-9. doi: 10.1016/j.jacc.2013.04.105. Epub 2013 Sep 26.
7
The effects and mechanisms of high loading dose rosuvastatin therapy before percutaneous coronary intervention in patients with acute coronary syndrome.急性冠状动脉综合征患者经皮冠状动脉介入治疗前高负荷剂量瑞舒伐他汀治疗的效果及机制
Int J Cardiol. 2013 Sep 1;167(5):2350-3. doi: 10.1016/j.ijcard.2012.11.032. Epub 2012 Nov 26.
8
Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary intervention.强化降脂在急性冠状动脉综合征和经皮冠状动脉介入治疗中的重要性。
J Interv Cardiol. 2007 Dec;20(6):447-57. doi: 10.1111/j.1540-8183.2007.00298.x.
9
Current statin usage for patients with acute coronary syndrome undergoing percutaneous coronary intervention: multicenter survey in Korea.接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者当前的他汀类药物使用情况：韩国多中心调查。
Clin Cardiol. 2012 Nov;35(11):700-6. doi: 10.1002/clc.22038. Epub 2012 Jul 23.
10
Rosuvastatin versus atorvastatin to prevent contrast induced nephropathy in patients undergoing primary percutaneous coronary intervention (ROSA-cIN trial).瑞舒伐他汀与阿托伐他汀预防接受直接经皮冠状动脉介入治疗患者的造影剂诱导肾病（ROSA-cIN试验）。
Acta Cardiol. 2013 Oct;68(5):489-94. doi: 10.1080/ac.68.5.2994472.